Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Michael J. Louie
Lipoprotein(a) Reductions From PCSK9 Inhibition and Major Adverse Cardiovascular Events: Pooled Analysis of Alirocumab Phase 3 Trials
Atherosclerosis
Cardiovascular Medicine
Cardiology
Related publications
Efficacy and Safety of Alirocumab in Patients With or Without Prior Coronary Revascularization: Pooled Analysis of Eight ODYSSEY Phase 3 Trials
Atherosclerosis
Cardiovascular Medicine
Cardiology
Saphenous Vein Graft Stenting and Major Adverse Cardiac Events: A Predictive Model Derived From a Pooled Analysis of 3958 Patients
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Predictors of Adverse Events Among Patients Undergoing Primary Percutaneous Coronary Intervention: Insights From a Pooled Analysis of the COMFORTABLE AMI and EXAMINATION Trials
EuroIntervention
Medicine
Cardiovascular Medicine
Cardiology
Major Adverse Cardiovascular Events in Treated Periodontitis: A Population-Based Follow-Up Study From Taiwan
PLoS ONE
Multidisciplinary
Association of Non-Alcoholic Fatty Liver Disease With Major Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis
Scientific Reports
Multidisciplinary
Cardiovascular Risks, Bleeding Risks, and Clinical Events From 3 Phase III Trials of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis
Advances in Therapy
Medicine
Pharmacology
Prognostic Value of Plasma Von Willebrand Factor Levels in Major Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis
BMC Cardiovascular Disorders
Cardiovascular Medicine
Cardiology
Delayed Adverse Events in Phase I Trials of Molecularly Targeted and Cytotoxic Agents
Oncotarget
Oncology
Preventing Major Adverse Cardiovascular Events by SGLT-2 Inhibition in Patients With Type 2 Diabetes: The Role of Kidney
Cardiovascular Diabetology
Internal Medicine
Cardiology
Endocrinology
Cardiovascular Medicine
Metabolism
Diabetes
